MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$6.99
+2.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.09x
- Price / sales
- 4.99x
- Price / cash flow
- -41.23x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 6.22x
- EV / EBITDA
- -23.38x
- EV / EBIT
- 13.52x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026